Proloxy

Proloxy is a financial services entity based in China, established on July 8, 2022. The company operates under the domain proloxy.com. As of this writing, publicly available information about Proloxy is extremely limited, and no official website content has been obtained to clarify its specific offerings.

Given the scarcity of independent data, traders should approach Proloxy with caution. The absence of verifiable operational details makes it difficult to assess the broker's legitimacy, services, or target market.

Our records indicate that Proloxy holds no regulatory licences from any known financial authority. This lack of oversight is a significant concern for traders, as unregulated brokers do not offer the same level of investor protection as those supervised by bodies such as the FCA, CySEC, or ASIC.

Without a regulatory framework, clients have no recourse through a financial ombudsman or compensation scheme in the event of disputes or malpractice. The FXCanary Scam Risk Score of 54/100 (Elevated) further reflects these risks.

Due to the absence of official website data, we cannot confirm what account types or trading platforms Proloxy offers. Typically, retail forex brokers provide demo and live accounts, but this remains unverified for this entity.

Traders are advised to request detailed information directly from the company and to scrutinise any documentation provided. The lack of visible platform information is a red flag that warrants further investigation.

No information is available regarding the financial instruments Proloxy may offer. It is unclear whether the broker provides forex, CFDs, commodities, cryptocurrencies, or other assets.

Similarly, funding methods and withdrawal policies are unknown. Without such information, prospective clients cannot evaluate the practicality or cost of using this broker.

Proloxy's target audience is uncertain. The limited details suggest it may aim at retail traders, but this is speculation. The broker's Chinese registration could indicate a focus on the domestic market, though no evidence confirms this.

Given the lack of transparency, the broker is not suitable for risk-averse traders or those who prioritise regulatory safety.

The lack of verifiable independent information about Proloxy is itself a cautionary sign. In the forex brokerage space, transparency is a key indicator of reliability.

Until Proloxy publishes clear details about its operations, regulation, and terms, we recommend traders exercise extreme caution or avoid the entity altogether.